Andrew Toth

Andrew Toth is an experienced professional in the field of material science and biocompatibility, currently serving as a Material Science R&D Engineer at Boston Scientific since May 2024. Prior roles include Biocompatibility Scientist at Abbott and Biocompatibility Specialist II at Teleflex Incorporated. Andrew has a strong background in biocompatibility engineering, hazard analysis, and toxicological risk assessment, with expertise in orthopedic implant safety evaluations compliant with ISO 10993 standards. Earlier positions involved conducting E&L testing at Medtronic, laboratory analysis at Pace Analytical, and research at the University of Minnesota-Twin Cities, where investigations focused on the roles of Heparan-Sulfate Proteoglycans in stem cell function. Andrew holds a Bachelor of Science degree in Biology and Chemistry from the University of Wisconsin-Superior.